At the end of March, we were in San Diego for the SOT conference! The week was packed with thought-provoking and exciting discussions. Thanks for everybody who came to meet us at #SOT2022! 🙏 Seeing your eyes widen in delight when you realize the potential that our cell culture devices hold, makes our work so
-> Continue reading Thanks for coming to see us at SOT 2022!
This year we are celebrating eNUVIO’s 6th anniversary! 🥳 Time flies when you are having fun! 🙏 Thanks to everybody who has been working with us in the last years, from scientists to distributors all around the world, amazing employees and consultants as well as supportive family members and friends. We wouldn’t be here without
-> Continue reading eNUVIO turned 6!
This was our first time at the #SLAS conference organized by the Society for Laboratory Automation and Screening and we want to take the opportunity to thank everybody who came to see us! We hope you liked not only our coasters but also our next-generation cell culture devices . It was such a pleasure meeting
-> Continue reading Thanks for visiting our booth at SLAS
Go check out the new publication in IPI! Neurological disorders are incredibly complex, and this is reflected in the lack of knowledge of the underlying pathological mechanism for many of these diseases, and in turn to the slow speed at which novel drug targets are identified. In this article, Mark Aurousseau, eNUVIO’s co-founder and CSO
-> Continue reading New Publication: Compartmentalised Microfluidic Devices for Drug Discovery in the Neurosciences
The article showcases Best Startup Canada’s top picks for the best MontrĂ©al based Biotechnology companies. We are on the list too!
Go check out the new publication by the Durcan lab from The Neuro! They describe in-depth how to scale up midbrain organoid generation using the EB-DISK. “In this study, we developed a method with microfabricated disks to scale up the generation of hMOs. This opens up the possibility to generate larger numbers of hMOs, in
-> Continue reading New Publication: Microfabricated disk technology: rapid scale up in midbrain organoid generation
Montreal, Canada, January 27th 2021 – On September 25th 2020 eNUVIO was pleased to introduce the latest microfabricated tool for neuronal compartmentalization and co-culture experiments: the OMEGA96. Today, eNUVIO officially announced the launch of this unique product, making the OMEGA96 the very first device of its kind. Modelled on the success of its predecessor, the
-> Continue reading eNUVIO is Launching the OMEGA96 Device
? Congrats to the authors of this collaborative work between Johns Hopkins University School of Medicine, Xuchang University and Tsinghua University. ? In this research, the authors observed that “nanozyme can block prion-like spreading, which provides a proof of concept for nanozyme therapy. It is also anticipated that the biomedical application of nanozyme against prion-like
-> Continue reading Nice study using our microfluidic Omega-4 devices
Montreal, Canada, December 8th 2020 – eNUVIO announced the release of the first completely reusable 3D cell culture microplate on the market. Scientific research currently consumes high-volumes of single-use plastics – from serological pipettes and pipette tips to vials and culture microplates – these are just a few of the many plastic items thrown
-> Continue reading eNUVIO is Launching the EB-Plate
